Vestmark Advisory Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.4M Buy
51,543
+17,781
+53% +$18M 0.53% 35
2025
Q4
$36.3M Buy
33,762
+16,217
+92% +$15.5M 0.49% 35
2025
Q3
$13.4M Buy
17,545
+4,400
+33% +$3.27M 0.26% 89
2025
Q2
$10.2M Sell
13,145
-10,557
-45% -$8.2M 0.15% 115
2025
Q1
$19.6M Buy
23,702
+11,591
+96% +$9.64M 0.5% 39
2024
Q4
$9.35M Buy
12,111
+1,332
+12% +$1.1M 0.32% 64
2024
Q3
$9.55M Buy
10,779
+692
+7% +$622K 0.36% 57
2024
Q2
$9.13M Sell
10,087
-811
-7% -$649K 0.38% 55
2024
Q1
$8.48M Sell
10,898
-310
-3% -$221K 0.37% 61
2023
Q4
$6.53M Sell
11,208
-475
-4% -$277K 0.33% 70
2023
Q3
$6.28M Sell
11,683
-8,588
-42% -$4.43M 0.46% 42
2023
Q2
$9.51M Buy
20,271
+971
+5% +$407K 0.36% 61
2023
Q1
$6.63M Buy
19,300
+2,181
+13% +$736K 0.29% 87
2022
Q4
$6.26M Buy
17,119
+534
+3% +$189K 0.31% 65
2022
Q3
$5.36M Sell
16,585
-107
-0.6% -$33.9K 0.3% 76
2022
Q2
$5.41M Buy
16,692
+3,988
+31% +$1.2M 0.31% 71
2022
Q1
$3.64M Buy
12,704
+547
+4% +$141K 0.21% 111
2021
Q4
$3.36M Buy
12,157
+364
+3% +$92.3K 0.19% 121
2021
Q3
$2.73M Buy
11,793
+1,869
+19% +$461K 0.18% 136
2021
Q2
$2.28M Buy
9,924
+592
+6% +$119K 0.16% 158
2021
Q1
$1.74M Buy
9,332
+585
+7% +$114K 0.15% 185
2020
Q4
$1.48M Buy
8,747
+489
+6% +$73K 0.17% 171
2020
Q3
$1.22M Sell
8,258
-1,541
-16% -$238K 0.16% 179
2020
Q2
$1.61M Buy
9,799
+127
+1% +$19.5K 0.25% 122
2020
Q1
$1.34M Sell
9,672
-729
-7% -$100K 0.26% 113
2019
Q4
$1.37M Sell
10,401
-1,521
-13% -$176K 0.28% 129
2019
Q3
$1.33M Buy
11,922
+2,216
+23% +$247K 0.22% 146
2019
Q2
$1.07M Sell
9,706
-1,434
-13% -$169K 0.18% 166
2019
Q1
$1.45M Buy
+11,140
New +$1.35M 0.26% 119

Other funds holding LLY

Vestmark Advisory Solutions's LLY Position: Q1 2026 in Review

Vestmark Advisory Solutions increased its Eli Lilly (LLY) stake by 53% in Q1 2026, buying an estimated $18M and bringing the position to 51,543 shares worth $47.4M. The position accounts for 0.53% of the portfolio, ranked #35.

Vestmark Advisory Solutions first reported a position in LLY in Q1 2019 and has held it in 29 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Vestmark Advisory Solutions held 51,543 shares of Eli Lilly worth $47.4M as of Q1 2026.
  • Vestmark Advisory Solutions bought 17,781 Eli Lilly shares in Q1 2026, an estimated $18M.
  • Eli Lilly made up 0.53% of Vestmark Advisory Solutions's portfolio in Q1 2026, its #35 holding.
  • Vestmark Advisory Solutions first reported a position in Eli Lilly in Q1 2019 and has held it in 29 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q1 2026, filed 15 May 2026.